Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 33538761.
- Also identified by DOI 10.1001/jamaoto.2020.5490 and PMC identifier 7863011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This randomized clinical trial investigates the efficacy of nasopharyngeal povidone iodine solutions in reducing the viral load of patients with COVID-19.
Medical subject headings
- Anti-Infective Agents, Local
- COVID-19
- Mouthwashes
- Nasal Sprays
- Nasopharynx
- Povidone-Iodine
- Viral Load